Advanced Pharmacy Residency

Pharmacy Leaders in Thrombosis Advanced Pharmacy Residency Available with Sunnybrook Health Sciences Centre

Date Posted:

Sunnybrook Health Sciences Centre offers a year-2 residency program for pharmacists in thrombosis management.  This program is built on the recognition that the prevention and management of thromboembolic disorders are important patient quality of care priorities for hospitalized and community patients.  The program is designed to help create capacity to effectively manage patients with respect to thromboembolic disorders by training pharmacists to have the advanced clinical skills and experience to be leaders in this aspect of patient care. 

Overall goals:

  • To foster competence in the areas of patient safety and quality improvement with specific emphasis on improving the effective and safe use of antithrombotic medications through the provision of evidence-based direct patient care as part of an inter-professional team
  • Managing components of the medication use system, pertaining to antithrombotic medications
  • Providing medication- and practice-related education to patients and other team members
  • To enhance individual skills and confidence so that the successful resident can become a thrombosis management practitioner, change agent and leader in this area locally and/or regionally
  • To develop project management and research skills through the completion of research projects in an area of relevance to thrombosis


The Pharmacy Leaders in Thrombosis Residency will consider applicants who express an interest in and commitment to advanced practice in the area of thrombosis. The applicant will be a registered pharmacist with one of the following:

  1. Doctor of Pharmacy as a second professional degree (i.e. post-baccalaureate), or
  2. Master’s degree in advanced pharmacotherapy, or
  3. Completion (or due to complete) an accredited year-1 Pharmacy residency. 

Summary of Program Activities

The advanced practice residency is a 1-year program (“Accreditation Pending” status by the Canadian Pharmacy Residency Board (CPRB)), with a proposed start date in September, 2019 (may be flexible upon request of the successful candidate). The option of combining the residency with a Master’s degree can be considered based on the interest of the applicant. 

The program will consist of:

  • A broad-based, formal curriculum designed to increase the pharmacist’s knowledge and understanding of the clinical science and operational practice of the prevention and treatment of venous and arterial thromboembolic disorders
  • Practical, clinical experience on the inpatient and outpatient thromboembolism service as well as the Cardiology and Vascular Surgery programs
  • Research in a relevant area of thrombosis practice.

Activities of the residency will also be tailored based on the needs and interests of the resident. 


A resident will receive $50,000 (+ benefits) per year of the program.

Interested applicants are asked to submit a letter of interest and a current curriculum vitae by June 24th, 2019 to:

Danette Beechinor, Director of Pharmacy
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room 305
Toronto, ON   M4N 3M5

Interviews of selected applicants will be scheduled on July 3rd and July 4th, 2019.